Advertising

NASDAQ:NTLA

47.74
0.03 (0.06%) 1d
0
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »
COMMENT
Announced positive early results in gene-editing that would treat a rare genetic disease that impacts 50,000 people. Shares shot up 50% today. Regeneron is their partner. Cathy Wood heavily invests in these stocks.
biotechnology
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Intellia Therapeutics(NTLA-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Intellia Therapeutics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Intellia Therapeutics(NTLA-Q) Frequently Asked Questions

What is Intellia Therapeutics stock symbol?

Intellia Therapeutics is a American stock, trading under the symbol NTLA-Q on the NASDAQ (NTLA). It is usually referred to as NASDAQ:NTLA or NTLA-Q

Is Intellia Therapeutics a buy or a sell?

In the last year, there was no coverage of Intellia Therapeutics published on Stockchase.

Is Intellia Therapeutics a good investment or a top pick?

Intellia Therapeutics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Intellia Therapeutics.

Why is Intellia Therapeutics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Intellia Therapeutics worth watching?

In the last year, there was no coverage of Intellia Therapeutics published on Stockchase.

What is Intellia Therapeutics stock price?

On 2022-05-20, Intellia Therapeutics (NTLA-Q) stock closed at a price of $47.74.